High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Knowing what to avoid when budgeting helps you stay on course. This piece highlights common missteps and practical countermeasures.
11,930 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
A steep stock drop can force tough choices. This article analyzes why a full exit from Cogent could matter to investo...
Momentum can flip quickly in growth stocks, but today some names look cheap for the upside potential. This guide high...
When a director sells shares after a sharp gain, it can spark questions about the stock’s future. This article breaks...
March has delivered a mixed bag for investors as oil swings, AI news, and private credit worries collide. This guide ...
Insider moves can reveal clues about a company's near-term prospects. This article dives into the remitly director's ...
The surge in late applied digital (apld) stock has many investors asking if the window to buy has closed. This guide ...
Nasdaq 100 enters correction territory as the S&P 500 fades in a five-week losing streak, with oil surging and politi...
A clear, practical guide to reading a 2026 earnings transcript. Learn which numbers matter, how management commentary...
Upstart’s growth engine faces higher costs that squeeze margins, triggering a drop in price even when revenue beats. ...
April brought a notable rally for Plug Power. This piece breaks down the forces behind the surge, what it signals for...
When Oshkosh released its latest results, the focus quickly shifted to a sharp stock move. This guide explains what h...